Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Literature
1.
Kim H, Lee SC, Kwon KY et al (2015) Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol PMID: 26626772
2.
Sanchez-Cano A, Orduna E, Segura F et al (2014) Choroidal thickness and volume in healthy young white adults and the relationships between them and axial length, ammetropy and sex. Am J Ophthalmol 158(3):574–583e1CrossRefPubMed
3.
Saeedi O, Pillar A, Jefferys J, Arora K, Friedman D, Quigley H (2014) Change in choroidal thickness and axial length with change in intraocular pressure after trabeculectomy. Br J Ophthalmol 98(7):976–979CrossRefPubMed
4.
Dedania VS, Bakri SJ (2015) Sustained elevation of intraocular pressure after intravitreal anti-vegf agents: What is the evidence? Retina 35(5):841–858CrossRefPubMed
5.
Hoang QV, Tsuang AJ, Gelman R et al (2013) Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy. Retina 33(1):179–187CrossRefPubMed
6.
Usui S, Ikuno Y, Akiba M et al (2012) Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci 53(4):2300–2307CrossRefPubMed
Metadata
Title
Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy
Authors
Salih Uzun
Emre Pehlivan
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3368-0

Other articles of this Issue 8/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2016 Go to the issue

Editorial (by Invitation)

Unexpected complications related to tamponade after vitrectomy

Basic Science

Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs

Retinal Disorders

Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats’ disease

Letter to the Editor (by invitation)

Reply to letter to the editor: Subfoveal Choroidal Thickness as a Predictor of Treatment Response to Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy

Cornea

Therapeutic dilemma in fungal keratitis: administration of steroids for immune rejection early after keratoplasty

Glaucoma

Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye